IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q1 2024 Holdings

Filed 2024-05-16 | 3 holdings | $72.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Omeros CorpNOTE 5.250% 2/1682143AG7$54.1M$72,979,00074.3%
Biora Therapeutics Inc.COM NEW74319F305$12.0M10,929,76216.5%
Puma Biotechnology Inc(PBYI)COM74587V107$6.7M1,256,4119.1%